FBLG logo

FibroBiologics, Inc. Stock Price

NasdaqCM:FBLG Community·US$16.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author

FBLG Share Price Performance

US$0.25
-1.52 (-85.78%)
US$0.25
-1.52 (-85.78%)
Price US$0.25

FBLG Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with adequate balance sheet.

6 Risks
0 Rewards

FibroBiologics, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$18.5m

Other Expenses

-US$18.5m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.28
0%
0%
3,658.4%
View Full Analysis

About FBLG

Founded
2021
Employees
13
CEO
Peter O’Heeron
WebsiteView website
fibrobiologics.com

FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases, including wound healing, multiple sclerosis, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications. The company was founded in 2021 and is based in Houston, Texas.

Recent FBLG News & Updates

Recent updates

No updates